297 related articles for article (PubMed ID: 22538522)
21. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
22. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
23. Combination DMARD therapy for rheumatoid arthritis.
Kremer JM
Manag Care; 2001 Jul; 10(7 Suppl):10-4. PubMed ID: 11729428
[No Abstract] [Full Text] [Related]
24. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Hochman D; Wolff B
JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763
[No Abstract] [Full Text] [Related]
25. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Callegari PE; Schaible TF; Boscia JA
JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762
[No Abstract] [Full Text] [Related]
26. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Costenbader KH; Glass R; Cui J; Shadick N
JAMA; 2006 Nov; 296(18):2201; author reply 2203-4. PubMed ID: 17090761
[No Abstract] [Full Text] [Related]
27. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
28. Rheumatoid arthritis.
Ramsburg KL
Am J Nurs; 2000 Nov; 100(11):40-3. PubMed ID: 11103634
[No Abstract] [Full Text] [Related]
29. Infliximab treatment of rheumatoid arthritis.
Maini SR
Rheum Dis Clin North Am; 2004 May; 30(2):329-47, vii. PubMed ID: 15172044
[TBL] [Abstract][Full Text] [Related]
30. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy.
Roos JC; Chilvers ER; Ostor AJ
J Rheumatol; 2007 Jan; 34(1):238-9; author reply 239. PubMed ID: 17216703
[No Abstract] [Full Text] [Related]
31. Infectious complications of biologic agents.
Martin-Mola E; Balsa A
Rheum Dis Clin North Am; 2009 Feb; 35(1):183-99. PubMed ID: 19481004
[TBL] [Abstract][Full Text] [Related]
32. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Okada SK; Siegel JN
JAMA; 2006 Nov; 296(18):2201-2; author reply 2203-4. PubMed ID: 17090760
[No Abstract] [Full Text] [Related]
33. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
[TBL] [Abstract][Full Text] [Related]
34. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
Geraghty EM; Ristow B; Gordon SM; Aronowitz P
Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458
[TBL] [Abstract][Full Text] [Related]
35. Is there a need for immunopharmacologic guidance of anti-tumor necrosis factor therapies?
Bendtzen K
Arthritis Rheum; 2011 Apr; 63(4):867-70. PubMed ID: 21452309
[No Abstract] [Full Text] [Related]
36. Cautionary note: a possible association between oral squamous cell carcinoma and tumor necrosis factor antagonists; need for oral screening.
Rahman N; Healy C; Flint SR; Stassen LF
J Clin Rheumatol; 2010 Jun; 16(4):197-9. PubMed ID: 20511984
[No Abstract] [Full Text] [Related]
37. Drug-induced lupus erythematosus in a patient treated with adalumimab.
Spillane AP; Xia Y; Sniezek PJ
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S114-6. PubMed ID: 17434034
[No Abstract] [Full Text] [Related]
38. Biologic agents for rheumatoid arthritis: 2008 and beyond.
Sweiss NJ; Hushaw LL
J Infus Nurs; 2009; 32(1 Suppl):S4-17; quiz S19-24. PubMed ID: 19142153
[TBL] [Abstract][Full Text] [Related]
39. Use of biologics for rheumatoid arthritis tempered by concerns over safety, cost.
Pressman Lovinger S
JAMA; 2003 Jun; 289(24):3229-30. PubMed ID: 12824197
[No Abstract] [Full Text] [Related]
40. Systemic listeriosis with adalimumab therapy.
Murphy G; Schmidt-Martin D; Hynes BG; Harney S
J Clin Rheumatol; 2009 Oct; 15(7):369-70. PubMed ID: 20009978
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
